A comprehensive view of Approved Drugs/Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca withdraws US COVID-19 vaccine application for Vaxzevria, shifts focus to antibody treatment Evusheld; Evusheld is approved in US to prevent COVID in immunocompromised people and in Europe as a preexposure prophylactic and as a treatment

Baxter introduces ExactaMix Pro next-generation automated nutrition compounder at ASHP Meeting; device combines enhanced security with more intuitive and efficient features and greater processing power as compared to Baxter’s ExactaMix product

India approves AstraZeneca’s Dapagliflozin for diabetes patients with chronic kidney disease; the drug significantly reduces risk of sustained estimated glomerular filtration rate, cardiovascular deaths, hospitalizations due to heart failure

AstraZeneca showcases strength of hematology portfolio and pipeline across multiple hard-to-treat conditions at ASH 2022 December 10-13; eight approved and potential new medicines to be featured across more than 10 types of blood cancers and rare diseases

World Health Organization updates emergency use listing for Novavax Nuvaxovid COVID-19 vaccine as a primary series in adolescents and as a booster in adults

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count